EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

88 hedge funds and large institutions have $365M invested in EyePoint Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 6 closing their positions.

Holders
88
Holders Change
+25
Holders Change %
+39.68%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
33
Reduced
14
Closed
6
Calls
$6.91M
Puts
$2.95M
Net Calls
+$3.96M
Net Calls Change
+$1.06M

Top Buyers

1
Franklin Resources
1
Franklin Resources
California
$60.6M
2
RCM
2
RA Capital Management
Massachusetts
$41.3M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$20.5M
4
SCM
4
Suvretta Capital Management
New York
$30.8M
5
Goldman Sachs
5
Goldman Sachs
New York
$7.61M

Top Sellers

1
DCM
1
Driehaus Capital Management
Illinois
$6.32M
2
HighTower Advisors
2
HighTower Advisors
Illinois
$3.66M
3
Deutsche Bank
3
Deutsche Bank
Germany
$157K
4
ACM
4
Altium Capital Management
New York
$2.75M
5
ACP
5
Acuta Capital Partners
California
$2.98M
Name Market Value Shares Shares
Change 		Shares
Change %
Franklin Resources
1
Franklin Resources
California
$60.6M 4,947,165 +1,772,828 +56%
EWM
2
Essex Woodlands Management
Texas
$51.3M 4,190,921 – –
RCM
3
RA Capital Management
Massachusetts
$41.3M 3,370,506 +1,160,000 +52%
SCM
4
Suvretta Capital Management
New York
$30.8M 2,519,700 +815,111 +48%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$23.9M 1,950,000 +186,969 +11%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$20.5M 1,671,183 +958,799 +135%
Citadel Advisors
7
Citadel Advisors
Florida
$18M 1,469,213 +522,789 +55%
BlackRock
8
BlackRock
New York
$17.6M 1,440,631 +249,998 +21%
Vanguard Group
9
Vanguard Group
Pennsylvania
$14.6M 1,188,970 +96,664 +9%
Goldman Sachs
10
Goldman Sachs
New York
$7.61M 622,018 +582,925 +1,491%
DCM
11
Driehaus Capital Management
Illinois
$6.32M 516,234 -235,207 -31%
SB
12
Samsara BioCapital
California
$5.88M 480,000 +30,000 +7%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$4.9M 400,000 +399,996 +9,999,900%
State Street
14
State Street
Massachusetts
$4.37M 357,361 +54,732 +18%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.3M 351,359 +7,206 +2%
Verition Fund Management
16
Verition Fund Management
Connecticut
$3.87M 316,149 +316,149 New
HighTower Advisors
17
HighTower Advisors
Illinois
$3.66M 298,804 -229,624 -43%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$3.41M 278,672 +210,623 +310%
ACP
19
Acuta Capital Partners
California
$2.98M 243,072 -126,791 -34%
ACM
20
Altium Capital Management
New York
$2.75M 225,000 -145,551 -39%
PI
21
Putnam Investments
Massachusetts
$2.75M 225,000 +225,000 New
EIM
22
Essex Investment Management
Massachusetts
$2.75M 224,229 +51,702 +30%
Two Sigma Investments
23
Two Sigma Investments
New York
$2.36M 193,015 +193,015 New
Northern Trust
24
Northern Trust
Illinois
$2.28M 186,027 -6,801 -4%
FAM
25
Fred Alger Management
New York
$2.23M 182,530 +61,617 +51%
1
2 3 4